An Updated Comprehensive Pharmacovigilance Study of Drug‐Induced Thrombocytopenia Based on FDA Adverse Event Reporting System Data

药物警戒 医学 不良事件报告系统 不利影响 优势比 肝素诱导血小板减少症 内科学 鲁索利替尼 药品 药理学 数据库 肝素 骨髓纤维化 骨髓 计算机科学
作者
Li Kun-yu,Shi Shuping,Chang Su,Cao Yiyue,Xiong Qinyu,Ting Zhang,Bin Wu
出处
期刊:The Journal of Clinical Pharmacology [Wiley]
卷期号:64 (4): 478-489 被引量:1
标识
DOI:10.1002/jcph.2389
摘要

Abstract Drug‐induced thrombocytopenia (DIT) deserves both clinical and research attention for the serious clinical consequences and high prevalence of the condition. The current study aimed to perform a comprehensive pharmacovigilance analysis of DIT reported in the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database, with a particular focus on drugs associated with thrombocytopenia events. A disproportionality analysis of DIT was conducted using reports submitted to FARES from January 2004 to December 2022. Both the information component (IC) and reporting odds ratio (ROR) algorithms were applied to identify an association between target drugs and DIT events. A total of 15,940,383 cases were gathered in FAERS, 168,657 of which were related to DIT events. The top 50 drugs ranked by number of cases and ranked by signal strength were documented. The top 5 drugs ranked by number of cases were lenalidomide (10,601 cases), niraparib (3726 cases), ruxolitinib (3624 cases), eltrombopag (3483 cases), and heparin (3478 cases). The top 5 drugs ranked by signal strength were danaparoid (ROR 37.61, 95%CI 30.46‐46.45), eptifibatide (ROR 34.75, 95%CI 30.65‐39.4), inotersen (ROR 34.00, 95%CI 29.47‐39.23), niraparib (ROR 30.53, 95%CI 29.42‐31.69), and heparin (ROR 28.84, 95%CI 27.76‐29.97). The top 3 involved drug groups were protein kinase inhibitors, antimetabolites, and monoclonal antibodies and antibody‐drug conjugates. The current comprehensive pharmacovigilance study identified more drugs associated with thrombocytopenia. Although the mechanisms of DIT have been elucidated for some drugs, others still require further investigation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
脑洞疼应助yyyhhh采纳,获得10
刚刚
wusj120完成签到,获得积分10
1秒前
1秒前
阿珍完成签到,获得积分10
1秒前
2秒前
紫愿完成签到 ,获得积分10
2秒前
2秒前
练习时长两年半应助hua采纳,获得10
2秒前
安安给安安的求助进行了留言
3秒前
朱光辉完成签到,获得积分10
4秒前
4秒前
5秒前
6秒前
7秒前
顺心夏山发布了新的文献求助10
7秒前
8秒前
李健应助TheDing采纳,获得200
8秒前
8秒前
科研通AI5应助章宇采纳,获得10
9秒前
小二郎应助小李顺利毕业采纳,获得10
10秒前
危机的晟睿完成签到,获得积分10
11秒前
12秒前
13秒前
hhhh发布了新的文献求助20
14秒前
15秒前
爆米花应助HeJiangle采纳,获得10
18秒前
LL发布了新的文献求助20
18秒前
19秒前
19秒前
tyh发布了新的文献求助10
19秒前
19秒前
张雷应助科研通管家采纳,获得10
20秒前
田様应助科研通管家采纳,获得10
20秒前
我是老大应助科研通管家采纳,获得10
20秒前
yx_cheng应助科研通管家采纳,获得10
20秒前
20秒前
赘婿应助科研通管家采纳,获得10
20秒前
Ava应助科研通管家采纳,获得10
20秒前
上官若男应助科研通管家采纳,获得10
20秒前
小二郎应助科研通管家采纳,获得10
20秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975816
求助须知:如何正确求助?哪些是违规求助? 3520159
关于积分的说明 11201128
捐赠科研通 3256541
什么是DOI,文献DOI怎么找? 1798347
邀请新用户注册赠送积分活动 877539
科研通“疑难数据库(出版商)”最低求助积分说明 806426